Stimson Susan P 4
4 · Intersect ENT, Inc. · Filed Apr 12, 2019
Insider Transaction Report
Form 4
Stimson Susan P
Vice President, Marketing
Transactions
- Sale
Common Stock
2019-04-10$29.13/sh−10,000$291,318→ 45,778 total - Exercise/Conversion
Common Stock
2019-04-10$18.90/sh+10,000$189,000→ 55,778 total - Exercise/Conversion
Stock Option (right to buy)
2019-04-10−10,000→ 15,000 totalExercise: $18.90Exp: 2026-01-14→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Includes 10,017 Restricted Stock Units.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2019.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.90 to $29.37, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F4]The vesting commencement date of the option is January 1, 2016. 1/48th of the shares subject to the option shall vest monthly thereafter over 48 months.